At CSANZ 2026, cardiologist Dr Joseph Assad presented the NOTIFY-HF study in the Ralph Reader Prize Session, the Cardiac Society of Australia and New Zealand's showcase for the region's strongest emerging clinical research.
NOTIFY-HF asks a deceptively simple question: implanted cardiac devices can identify physiological deterioration before a heart-failure event, so can that information be made more useful by communicating it directly to patients, and helping them respond earlier?
It's the patient-facing half of remote monitoring that most programmes leave unbuilt. Device data typically flows to clinics, queues for review, and reaches the patient late or not at all. NOTIFY-HF closes that loop, turning a device signal into something the patient themselves can see and act on. The Clinician's platform supported the study's patient-facing arm, delivering that communication along the care pathway.
The study, several years of work and a major part of Dr Assad's PhD under A/Prof Hany Dimitri at Liverpool Hospital, was selected as a Ralph Reader Prize finalist, an honour reserved for a handful of researchers across Australia and New Zealand each year.
We're proud to have played a supporting role, and prouder still of what the study represents: the same conviction that runs through everything we build, that the patient's voice, and the patient's hands, belong inside the loop of care.
Congratulations, Joe, and to all the CSANZ 2026 finalists.